Arbutus Biopharma - Investor Relations
OVERVIEW
INVESTOR.ARBUTUSBIO.COM TRAFFIC
Date Range
Date Range
Date Range
LINKS TO INVESTOR.ARBUTUSBIO.COM
WHAT DOES INVESTOR.ARBUTUSBIO.COM LOOK LIKE?
INVESTOR.ARBUTUSBIO.COM SERVER
SERVER SOFTWARE
We detected that this domain is implementing the Microsoft-IIS/6.0 operating system.SITE TITLE
Arbutus Biopharma - Investor RelationsDESCRIPTION
The Baruch S. Blumberg Institute. Surface Antigen Secretion Inhibitors. Oncology, Anti-virals and Metabolic Programs. RNAi Collaborators and Partners. HBV Collaborators and Partners. Arbutus Biopharma is a publicly-traded NASDAQTKMR. In addition to our HBV Assets. We are developing a pipeline of Oncology, Anti-viral and Metabolic Programs. That leverage our expertise in RNA interference RNAi. Therapeutics and our Lipid Nanoparticle LNP. View all . Aug 7, 2015. Aug 5, 2015. View all .PARSED CONTENT
The site investor.arbutusbio.com had the following on the homepage, "Oncology, Anti-virals and Metabolic Programs." I noticed that the webpage said " Arbutus Biopharma is a publicly-traded NASDAQTKMR." They also stated " In addition to our HBV Assets. We are developing a pipeline of Oncology, Anti-viral and Metabolic Programs. That leverage our expertise in RNA interference RNAi. Therapeutics and our Lipid Nanoparticle LNP."SEE MORE WEB SITES
Spectrum Pharmaceuticals Reports Second Quarter 2015 Financial Results and Pipeline Update. Spectrum Pharmaceuticals Announces Second Quarter 2015 Financial Results Teleconference and Webcast. Delayed at least 20 minutes. Annual report and proxy information.
Headquartered in Memphis, Tennessee, with a business center in Miamisburg, Ohio, Verso operates eight mills strategically located in Kentucky, Maine, Maryland, Michigan, Minnesota and Wisconsin with a total annual production capacity of approximately 3. Second Quarter 2015 Earnings Conference Call.
Zimmer Biomet - Delivering Value. Founded in 1927 and headquartered in Warsaw, Indiana, USA, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Recent News Releases and Information. Zimmer Completes Combination with Biomet.
Last twelve month annual sales. Adjusted EPS growth over the last five years. Free cash flow returned to shareholders over the last five years. Announces Results for the Fourth Quarter and Fiscal Year 2015. ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical.
Sign In or Create An Account. August 12, 2015 by Nithya Ruff.